EUVIMEDEUVIMED entdecken
Crossref

Development and Validation of a Targeted Treatment for Brain Tumors Using a Multi-Drug Loaded, Relapse-Resistant Polymeric Theranostic

Weijing Chu iD, Zachary H Houston iD, Nicholas L Fletcher iD, Pie Huda iD, Muneer Ahamed iD, Ting Xiang Lim iD, Bryan W Day, Mark Pinkham, Kristofer J Thurecht iD

Biomacromolecules · 2023

DOI: 10.1021/acs.biomac.3c00138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, 2023. Verfasst von Weijing Chu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland 4072, Australia. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: National Health and Medical Research Council, Australian Research Council, University of Queensland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsHumansPharmaceutical PreparationsPrecision MedicineNeoplasm Recurrence, LocalTemozolomidePolymersCell Line, TumorDrug Resistance, NeoplasmXenograft Model Antitumor AssaysTumor Microenvironment

Substanzen

Pharmaceutical PreparationsTemozolomidePolymers

Autor:innen und Institutionen

  • Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland 4072, Australia.
  • Centre for Advanced Imaging, The University of Queensland, Brisbane, Queensland 4072, Australia.
  • ARC Centre of Excellence in Convergent BioNano Science and Technology, The University of Queensland, Brisbane, Queensland 4072, Australia.
  • ARC Training Centre for Innovation in Biomedical Imaging Technology, The University of Queensland, Brisbane, Queensland 4072, Australia.
  • QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
  • School of Medicine, The University of Queensland, Brisbane, Queensland 4072, Australia.

ORCID-Profile: Weijing Chu, Zachary H Houston, Nicholas L Fletcher, Pie Huda, Muneer Ahamed, Ting Xiang Lim, Kristofer J Thurecht

Förderung

  • National Health and Medical Research Council
  • Australian Research Council
  • University of Queensland

Zitieren

APA

Chu, W., Houston, Z. H., Fletcher, N. L., Huda, P., Ahamed, M., Lim, T. X., Day, B. W., Pinkham, M., & Thurecht, K. J. (2023). Development and Validation of a Targeted Treatment for Brain Tumors Using a Multi-Drug Loaded, Relapse-Resistant Polymeric Theranostic. Biomacromolecules. https://doi.org/10.1021/acs.biomac.3c00138

Vancouver

Chu W, Houston ZH, Fletcher NL, Huda P, Ahamed M, Lim TX, et al. Development and Validation of a Targeted Treatment for Brain Tumors Using a Multi-Drug Loaded, Relapse-Resistant Polymeric Theranostic. Biomacromolecules. 2023. doi:10.1021/acs.biomac.3c00138

BibTeX
@article{Chu2023,
  author = {Chu, Weijing and Houston, Zachary H and Fletcher, Nicholas L and Huda, Pie and Ahamed, Muneer and Lim, Ting Xiang and Day, Bryan W and Pinkham, Mark and Thurecht, Kristofer J},
  title = {Development and Validation of a Targeted Treatment for Brain Tumors Using a Multi-Drug Loaded, Relapse-Resistant Polymeric Theranostic},
  journal = {Biomacromolecules},
  year = {2023},
  doi = {10.1021/acs.biomac.3c00138}
}
Kostenlos starten →